GLP-3R is used in research to explore “next-generation” weight loss results and the reversal of fatty liver disease. It is studied for its ability to increase energy expenditure more effectively than previous generations of metabolic peptides. Scientifically, it is a “triple agonist” peptide that targets the GIP, GLP-1, and Glucagon receptors, providing a three-pronged approach to regulating glucose, insulin, and fat metabolism.